公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
公司地址 9715 Key West Avenue, Rockville, MD, USA, 20850
電話號碼 +1 301 838-2500
傳真號碼 --
公司網頁 https://www.supernus.com
員工數量 778
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Frank Mottola Senior Vice President, Quality, GMP Operations and IT 美元 378.43K 24/02/2026
Mr. Padmanabh P. Bhatt Senior Vice President, Intellectual Property and Chief Scientific Officer 美元 441.03K 30/04/2025
Dr. Jonathan Rubin, M.B.A.,M.D. Senior Vice President and Chief Medical Officer, Research and Development 美元 467.50K 30/04/2025
Mr. Jack A. Khattar Director, President, Chief Executive Officer and Secretary 美元 1.01M 02/03/2026
Mr. Timothy C. Dec Senior Vice President, Principal Accounting Officer and Chief Financial Officer 美元 486.82K 02/03/2026
 
董事會成員
董事會 職務 更新日期
Mr. Frederick M. Hudson Independent Director 02/03/2026
Dr. Carrolee Barlow, M.D.,PhD Independent Director 02/03/2026
Mr. Jack A. Khattar Director, President, Chief Executive Officer and Secretary 02/03/2026
Dr. Georges Gemayel,PhD Independent Director 02/03/2026
Mr. Charles W. Newhall, III Chairman of the Board 02/03/2026
Ms. Bethany L. Sensenig Independent Director 02/03/2026
 
所屬ETF (更新日期: 07/03/2026 03:37)
代號 名稱 佔比% 持有日期
BIBProShares Ultra Nasdaq Biotechnology0.005%27/02/2026
FTXHFirst Trust Nasdaq Pharmaceuticals ETF0.005%26/02/2026
ITWOProShares Russell 2000 High Income ETF0.004%27/02/2026
OASCOneAscent Enhanced Small and Mid Cap ETF0.004%27/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.004%28/02/2026
ISCBiShares Morningstar Small-Cap ETF0.004%28/02/2026
BKSEBNY Mellon US Small Cap Core Equity ETF0.003%28/02/2026
AVTMAvantis Total Equity Markets ETF0.003%28/02/2026
RFLRInnovator U.S. Small Cp Mgd Flr ETF0.002%25/02/2026
ESSCEventide Small Cap ETF0.002%27/02/2026
AVSUAvantis Responsible US Equity ETF0.002%28/02/2026
FNDBSchwab Fundamental U.S. Broad Market ETF0.002%28/02/2026
VLUState Street® SPDR® S&P® 1500 ValTiltETF0.001%27/02/2026
SAAProShares Ultra SmallCap6000.001%27/02/2026
ACSVAmerican Century Small Cp Val Insgts ETF0.001%28/02/2026
ESIXState Street® SPDR® S&P SmCap 600 ESGETF0.001%27/02/2026
SEISSEI Select Small Cap ETF0.001%27/02/2026
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0005%31/05/2023
MMTMState Street® SPDR® S&P® 1500MomtTiltETF0.0005%27/02/2026
KBFRInnovator U.S. Small Cap Mgd 10 Bfr ETF0.0003%27/02/2026
  1    2    3    4   5    6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.